Latest news
Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 10:55:00 GMTCboe Completes Sale of Cboe Australia to TMX Group - The Malaysian ReserveThe Malaysian Reserve · Sun, 02 Aug 2026 21:48:22 GMTNitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial - AOL.comAOL.com · Tue, 28 Jul 2026 13:44:12 GMT